Check out our most popular compounded medications! Get Started
Ephedrine Sulfate 75 mg Slow Release Capsules, formulated with Methocel E4M, provide a gradual release of the active ingredient. This controlled-release mechanism ensures sustained therapeutic effects for conditions such as asthma, bronchitis, and hypertension. The extended release profile and reduced dosing frequency enhance patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ephedrine Sulfate 75 mg Slow Release Capsules are a meticulously compounded formulation, specifically designed to treat a variety of conditions such as asthma, bronchitis, and allergies. This prescription medication is formulated with Methocel E4M, a type of controlled-release polymer. This polymer ensures the gradual and controlled release of the active ingredient, ephedrine sulfate, over an extended period. This slow and steady release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that necessitate a controlled and prolonged release profile.
Ephedrine sulfate is a sympathomimetic amine that functions by stimulating the sympathetic nervous system. This action helps to alleviate airway constriction and enhance breathing. Additionally, it aids in reducing inflammation and swelling in the airways, thereby alleviating the symptoms of asthma, bronchitis, and allergies. The slow release of this active ingredient ensures a steady and prolonged therapeutic effect, providing relief from symptoms over an extended period.
However, it is crucial to adhere to your healthcare provider's instructions when taking this medication. Misuse, such as taking higher doses or using it for longer periods than recommended, can lead to serious side effects. It is important to remember that this medication is designed to provide a slow and steady release of the active ingredient, and altering the dosing schedule can disrupt this mechanism and potentially lead to adverse effects.
If you have any queries about Ephedrine Sulfate 75 mg Slow Release Capsules, please do not hesitate to reach out. Our team of compounding pharmacists is well-equipped with the knowledge and expertise to assist you. We are committed to providing comprehensive information and guidance to ensure the safe and appropriate use of this medication.
Ephedrine Sulfate 75 mg Slow Release Capsules are meticulously formulated with Methocel E4M, a controlled-release polymer. This innovative design ensures the gradual release of the encapsulated medication over an extended period, thereby providing sustained therapeutic effects. This formulation also aids in reducing the dosing frequency and enhancing patient compliance, particularly for medications that necessitate a controlled and prolonged release profile.
It is important to note that these capsules may interact with other medications, supplements, or herbal products. Therefore, it is crucial for patients to disclose all medications, supplements, and herbal products they are currently taking to their healthcare provider before initiating this medication. Patients are strongly advised not to start, stop, or alter the dosage of any medications without prior consultation with their healthcare provider.
Ephedrine Sulfate 75 mg Slow Release Capsules may interact with monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, and other sympathomimetic agents. Patients who are currently on MAOIs or tricyclic antidepressants are advised against taking this medication. Those taking other sympathomimetic agents should exercise caution when taking this medication.
Interactions may also occur with anticoagulants, beta-blockers, and other medications that influence the cardiovascular system. Patients who are on anticoagulants or beta-blockers should exercise caution when taking this medication.
These capsules may also interact with diuretics, antihypertensives, and other medications that affect blood pressure. Patients who are on diuretics or antihypertensives should exercise caution when taking this medication.
Ephedrine Sulfate 75 mg Slow Release Capsules may interact with anticonvulsants, antipsychotics, and other medications that affect the central nervous system. Patients who are on anticonvulsants or antipsychotics should exercise caution when taking this medication.
This medication is primarily used to treat asthma, bronchitis, and other respiratory conditions. Patients should inform their healthcare provider of any other medical conditions they have before taking this medication.
If you have any questions about the interactions of Ephedrine Sulfate 75 mg Slow Release Capsules, please consult with your healthcare provider.
Ephedrine Sulfate 75 mg Slow Release Capsules are a specially compounded formulation designed to provide relief from various respiratory conditions such as asthma, bronchitis, and nasal congestion. The unique feature of these capsules is the incorporation of Methocel E4M, a controlled-release polymer. This polymer facilitates a slow, steady release of the active ingredient, ephedrine sulfate, over an extended duration. This gradual release mechanism ensures sustained therapeutic effects, thereby reducing the frequency of dosing and enhancing patient compliance, especially for medications that necessitate a controlled and prolonged release profile.
The active ingredient in these capsules, ephedrine sulfate, functions by stimulating the release of adrenaline. This biochemical action aids in opening up the airways and reducing inflammation, thus providing relief from the symptoms of asthma, bronchitis, and nasal congestion. Additionally, it can help mitigate the severity of an asthma attack.
These capsules are typically administered orally, once or twice daily, depending on the severity of the condition being treated. It is of utmost importance to adhere to the instructions provided by your healthcare provider when taking Ephedrine Sulfate 75 mg Slow Release Capsules. Exceeding the recommended dose can escalate the risk of side effects. Maintaining consistency in the timing of the doses is also crucial, as it ensures a steady release of the medication, thereby maximizing its therapeutic benefits.
If you have any queries or concerns regarding Ephedrine Sulfate 75 mg Slow Release Capsules, please consult your healthcare provider or pharmacist. They possess the requisite knowledge and expertise to provide you with appropriate guidance and support. Remember, it's always important to communicate openly with your healthcare team about your medication regimen and any potential concerns you may have.
Ephedrine Sulfate 75 mg Slow Release Capsules are a specially compounded formulation that utilizes Methocel E4M, a controlled-release polymer. This polymer allows for the gradual release of the active ingredient, Ephedrine Sulfate, over an extended period of time. The slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that necessitate a controlled and prolonged release profile.
Ephedrine Sulfate in this formulation has been employed in the management of a variety of health conditions. It has been used to treat respiratory conditions such as asthma, bronchitis, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.
Moreover, Ephedrine Sulfate 75 mg Slow Release Capsules have been used to manage narcolepsy, a sleep disorder characterized by excessive daytime sleepiness. In certain cases, it has been used to treat hypotension, a condition where the blood pressure is abnormally low. It has also been used to alleviate the symptoms of opioid withdrawal.
Furthermore, Ephedrine Sulfate has been used to increase alertness and reduce fatigue. Some individuals have used it to enhance athletic performance, although this use is not recommended due to potential side effects. It is important to consult with a healthcare professional before starting any new medication regimen. If you have any questions about the use of Ephedrine Sulfate 75 mg Slow Release Capsules, please consult with your healthcare provider.
Ephedrine Sulfate 75 mg Slow Release Capsules is a medication that contains the active ingredient Ephedrine Sulfate. It is formulated with Methocel E4M, a type of controlled-release polymer, designed to release the medication gradually over an extended period of time.
Methocel E4M is a controlled-release polymer that is used in the formulation of these capsules. It is designed to release the encapsulated medication or active ingredient gradually over an extended period of time, offering sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.
Slow release capsules offer several benefits. They provide sustained therapeutic effects, reduce the frequency of dosing, and improve patient compliance, especially for medications that require a controlled and prolonged release profile.
The dosing frequency of Ephedrine Sulfate 75 mg Slow Release Capsules will depend on your doctor's prescription. The slow release formulation is designed to reduce the frequency of dosing, but it's important to follow your doctor's instructions.
If you miss a dose, take it as soon as you remember. If it's close to the time for your next dose, skip the missed dose and go back to your regular schedule. Do not take two doses at the same time or extra doses. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
No, you should not break or crush the capsules. Doing so can interfere with the controlled-release mechanism and may lead to a sudden release of the medication, which could potentially be harmful.
Like all medications, Ephedrine Sulfate 75 mg Slow Release Capsules can have side effects. These can include nervousness, restlessness, dizziness, headache, nausea, loss of appetite, or weight loss. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
If you are pregnant or breastfeeding, you should consult your doctor before taking Ephedrine Sulfate 75 mg Slow Release Capsules. Your doctor will be able to advise you on the potential risks and benefits.
It's generally recommended to avoid alcohol while taking medication. Alcohol can interact with many drugs and can increase the risk of side effects. Always consult your healthcare provider for advice.
Before starting any new medication, including over-the-counter drugs and dietary supplements, you should always consult your doctor or pharmacist. They will be able to advise you on potential interactions with Ephedrine Sulfate 75 mg Slow Release Capsules.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
